Types of Chronic Wounds: Indications for Enzymatic Débridement
The role of proteolytic enzymes in wound healing can no longer be seen as mere wound débridement Rather it should be considered as a single, but important player in the wound healing orchestra. Proteolytic enzymes are a family of proteins that serve to degrade necrotic débris derived from cell breakdown. They are produced endogenously often as precursor proteins whose activation is precisely regulated. These activated enzymes serve many functions in normal as well as pathological situations. In particular they are involved in the regulation of cell maturation and multiplication; collagen synthesis and turnover; celt deformation, migration and reepithelialisation; the development and removal of the perivascular fibrin cuffs found in venous insufficiency and leg ulceration, as well as the removal of dead tissues following inflammation. As a limited number of enzymes perform all these functions, it is difficult to predict the effects of applying synthetic proteolytic enzymes to a wound. Many such enzymes are currently commercially available and being promoted as alternatives to surgical wound débridement. It is important for their use to be considered in the context of their interaction with endogenous proteases, their physiological role in tissue, their ability to reach a desired target and the stage of wound healing at the time they are applied. Empirical observations and conventional wisdom however, support the view that sloughy wounds need to be débrided.
KeywordsWound Healing Proteolytic Enzyme Lytic Enzyme Venous Insufficiency Venous Ulcer
Unable to display preview. Download preview PDF.
- 1.Elliot IMZ (1964) A short history of surgical dressings Pharmaceutical Press. LondonGoogle Scholar
- 4.Ryan TJ (1983) The management of leg ulcers. Oxford Medical Publishers. OxfordGoogle Scholar
- 5.Cherry GW, Cherry CA, Jones RL, et al (1988) Clinical experience with DuoDERM in venous ulcers and clot resolution in experimental full thickness wounds. In: Cederholm-Williams SA, Ryan TJ, Lydon MJ (eds) Fibrinolysis and angiogenesis in wound healing. Excerpta Medica, Princeton, pp 19–23Google Scholar
- 6.Carpenter BG, Hill SS (1993) Varidase ® — the science behind the medicament. (Unpublished)Google Scholar
- 10.Ryan TJ (1969) The epidermis and its blood supply in venous disorders of the legs. Trans St John’s Hospital Dermatol Soc 59: 51Google Scholar
- 11.Bollinger A, Speiser D, Haselbach P, Jager K (1988) Microangiopathy of mild and severe chronic venous incompetence studied by fluorescence videomicroscopy. Schweiz Med WochenschGoogle Scholar
- 18.Mulder G, Jones R, Cederholm-Williams S, Cherry G, Ryan T (1992) Fibrin cuff lysis in chronic venous ulcers treated with a hydrocolloid dressing. International J Dermatol 32:1–8Google Scholar
- 22.Parish C (1986) Cutaneous elastin degradation in ageing and inflammation. Cosmetic Dermatology 1: 97–112Google Scholar
- 34.Lazarus GS, Schectler N, Jensen P, et al (1991) Proteinase metabolism in the human skin: The role of plasminogen activator and mast cell proteinases in cutaneous biology. In: Goldsmith LA. Physiology, Biochemistry, and Molecular Biology of the Skin. Second Edition. Oxford University Press, p 462-479Google Scholar